Sugary Drinks Tied to 2M Diabetes Cases; Diagnosing LADA; Top GLP-1 for Weight Loss
Investigational once-weekly retatrutide yielded the greatest weight loss of all GLP-1 receptor agonists, up to 22.1% after 48 weeks in adults with overweight or obesity and withou
GLP-1 RAs efficacious for weight loss in overweight, obesity without diabetes
For adults with overweight or obesity without diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are efficacious for weight loss, according to a review published online Jan. 7 in the Annals of Internal Medicine.
Some GLP-1s Achieve More Weight Loss Than Others: Study
We found that, of the 12 GLP-1 (drugs) identified by our search, the greatest mean body weight reduction was reported in randomized controlled trials of retatrutide, tirzepatid
How do GLP-1 drugs work for weight loss?
Dr. Mehmet Furkan Burak said people who have lost weight and then gained it again can feel guilt or shame and blame themselves for it.
How Effective Are GLP-1 Meds for Weight Loss in People Without Diabetes?
At least 95 people have been killed. How Effective Are GLP-1 Meds for Weight Loss in People Without Diabetes? A pensioner living next to a new major road project will access his home through a 'private' TUNNEL - that could cost up to £6M.
Health Matters: GLP-1 drugs work for weight loss, study finds
McGill University researchers say their study has found GLP-1 drugs are safe and effective for treating obesity and overweight adults without diabetes. The authors say the findings support using the medication to treat those who are overweight and obese among otherwise healthy patients.
Fierce Healthcare5h
Found introducing oral dissolvable GLP-1 tablet at reduced price
Weight management platform Found is today launching oral semaglutide dissolvable tablets for individuals looking for ...
Gala GLP1: The App Revolutionizing GLP-1 Treatment Management
With its innovative features and the upcoming launch of a direct medication purchasing service, Gala is set to become the ...
FierceBiotech1d
Metsera links GLP-1 drug to 11% weight loss after 12 weeks, teeing up trial of monthly dosing
Metsera has linked its GLP-1 drug candidate to weight loss of up to 11.3% after 12 weeks, encouraging the biotech to use some ...
FoodNavigator8h
Which GLP-1 drugs are on the market?
A range of GLP-1 weight loss drugs are currently on the market. What are they, what do they do, and where are they available?
Medscape1d
Early Intervention Central to Treating Muscle Mass Loss in Patients Losing Weight With GLP-1 Meds
Research showed that patients who lose weight on GLP-1 agonists frequently experience muscle mass loss. Obesity experts share ...
thecardiologyadvisor.com4h
GLP-1 Receptor Agonists Reduce Risk of CKD Progression, ESKD, and MACE
Glucagon-like peptide-1 receptor agonists (GLP-1 RA) significantly reduce the risk for clinically meaningful chronic kidney disease (CKD) progression and major adverse cardiovascular events (MACE) in ...
News Medical on MSN2d
Do GLP-1 receptor agonists increase the risk of suicide in patients?
A nationwide study confirms GLP-1 RAs pose no short-term psychiatric risk, showing a negative association with suicidal ...
FoodNavigator1d
What do GLP-1-taking consumers really want from food and drink?
What can people eat and drink when taking GLP-1 drugs like Ozempic to help them lose weight? FoodNavigator explores ...
GLP-1 makers could be under pressure in 2025
Atlanta Falcons wide receiver Drake London catches a 20-yard touchdown pass from quarterback Michael Penix Jr. "Hey, I’m ...
News Medical on MSN1d
GLP-1 drugs linked to fewer post-surgical complications in diabetic patients
People with diabetes who were taking GLP-1 receptor agonist drugs such as tirzepatide and semaglutide had significantly lower rates of hospital readmission, wound re-opening and hematoma after surgery ...